Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer’s disease: a meta-analysis
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Studies of the relationship between Alzheimer's disease (AD) and polymorphism in the promoter region of Interleukin 6 (IL-6) -174 G/C have reported inconsistent results. To assess the association between IL-6 -174 G/C promoter polymorphism and AD risk, a meta-analysis containing 3,101 AD cases and 3,860 controls from 18 case-control studies was performed. There were 16 studies involving Europeans and 2 studies involving non-Europeans. The combined results showed significant differences in recessive model [CC versus GC + GG, odds ratio (OR) = 0.70, 95% confidence interval (CI) = 0.54-0.90] and heterozygote comparison (CC versus GC, OR = 0.76, 95% CI = 0.60-0.96) on the basis of all studies. On subgroup analysis by ethnicity, similarly significant differences in recessive model (CC versus GC + GG) were found in both Europeans and non-Europeans, but significant difference in heterozygote comparison (CC versus GC) was found only in non-Europeans. In conclusion, there were statistically significant differences in genotype distribution of IL-6 -174 G/C between AD cases and controls in recessive model (CC versus GC + GG). Genotype CC of IL-6 -174 G/C could decrease the risk of AD. Further studies with large sample size, especially in subgroup analysis, should be done.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Carriers of the−174G > C mutation have an increased risk of developing various major diseases, including Alzheimer disease30, CVD31, non-insulin-dependent diabetes mellitus32, bone fragility33, and systemic-onset juvenile chronic arthritis34.”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [30]
Citations
Cites
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370
Wada, K., Tanaka, K., & Nakashima, K. (2011) · PubMed · Cited by 1,132
Cytokines and cognition–the case for a head-to-toe inflammatory paradigm.
Wilson, C. J., Finch, C. E., & Cohen, H. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50619.x · Cited by 637
Licastro, F., Grimaldi, L. M. E., Bonafè, M., Martina, C., Olivieri, F., Cavallone, L., Giovanietti, S., Masliah, E., & Franceschi, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00013-7 · Cited by 182
Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer’s disease
Arosio, B., Trabattoni, D., Galimberti, L., Bucciarelli, P., Fasano, F. R., Calabresi, C., Cazzullo, C. L., Vergani, C., Annoni, G., & Clerici, M. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.009 · Cited by 156
Transgenic models to assess the pathogenic actions of cytokines in the central nervous system
Campbell, I. L., Stalder, A. K., Chiang, C.-S., Bellinger, R., Heyser, C. J., Steffensen, S. C., Masliah, E., Powell, H. C., Gold, L. H., Henriksen, S. J., et al. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000225 · Cited by 99
Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease
Bhojak, T., DeKosky, S. T., Ganguli, M., & Kamboh, M. I. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01185-x · Cited by 99
Shibata, N., Ohnuma, T., Takahashi, T., Baba, H., Ishizuka, T., Ohtsuka, M., Ueki, A., Nagao, M., & Arai, H. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10417 · Cited by 80
Genetics of interleukin 6: implications for Alzheimer's disease
Papassotiropoulos, A., Hock, C., & Nitsch, R. M. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00294-9 · Cited by 78
Bagli, M., Papassotiropoulos, A., Knapp, M., Jessen, F., Rao, M. L., Maier, W., & Heun, R. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00917-4 · Cited by 75
Cited by
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Microglial dysfunction connects depression and Alzheimer’s disease
Santos, L. E., Beckman, D., & Ferreira, S. T. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.011 · Cited by 154
“In addition, IL-6 polymorphisms, also risk factors for AD (Chen et al., 2012; Dai et al., 2012), were linked to impaired therapeutic response in depressed patients (Bufalino et al., 2013).”
BackgroundCirculating interleukin‐6 concentration and cognitive decline in old age: the PROSPER study
Mooijaart, S. P., Sattar, N., Trompet, S., Lucke, J., Stott, D. J., Ford, I., Jukema, J. W., Westendorp, R. G. J., & de Craen, A. J. M. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12052 · Cited by 117
Genetics of human longevity within an eco-evolutionary nature-nurture framework
Giuliani, C., Garagnani, P., & Franceschi, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.312562 · Cited by 92
Metadata
- Authors
- Dai, L., Liu, D., Guo, H., Wang, Y., & Bai, Y.
- Affiliations
- Army Medical University (CN)
- Corresponding author
- Bai, Yun
- Venue
- Journal of Neurology
- Published
- 2011-07-12
- Volume
- 259
- Issue
- 3
- Pages
- 414-419
- ISSN
- 0012-1037 (ISSN-L)
- 0340-5354
- 1432-1459
- OpenAlex
- W2078030453
- Cited by
- 32
- References
- 27
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 5 · 2013: 5 · 2012: 2
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, interleukin-6, IL-6 -174 G/C polymorphism, promoter polymorphism, genetic susceptibility, recessive model, ethnic differences, case-control study
- MeSH terms
- Alzheimer Disease, Ethnicity, Humans, Promoter Regions, Genetic, Interleukin-6, Databases, Bibliographic, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer’s disease: a meta-analysis. https://app.cochat.ai/papers/10.1007/s00415-011-6164-0
- The paper
- Dai, L., Liu, D., Guo, H., Wang, Y., & Bai, Y. (2012). Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer’s disease: a meta-analysis. Journal of Neurology. https://doi.org/10.1007/s00415-011-6164-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.